Episurf Medical AB (publ) (EPIS-B) — Working Capital to Net Assets Ratio
Episurf Medical AB (publ) (EPIS-B) has a Working Capital to Net Assets ratio of 15.4% as of December 2025. Working capital of Skr7.30 Million (current assets of Skr17.70 Million minus current liabilities of Skr10.40 Million) is measured against net assets of Skr47.50 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Episurf Medical AB (publ) free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Episurf Medical AB (publ) Working Capital to Net Assets (2009–2025)
This chart shows how Episurf Medical AB (publ)'s Working Capital to Net Assets ratio has evolved across 17 annual periods from 2009 to 2025. As of December 2025, the ratio stands at 15.4%, reflecting working capital of Skr7.30 Million against net assets of Skr47.50 Million SEK. See Episurf Medical AB (publ) defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Episurf Medical AB (publ) (2009–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Episurf Medical AB (publ) from 2009 to 2025, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Episurf Medical AB (publ) (EPIS-B) market capitalisation.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 15.4% | Skr7.30 Million | Skr47.50 Million | Skr17.70 Million | Skr10.40 Million | ▼ -39.3 pp |
| 2024 | 54.7% | Skr45.80 Million | Skr83.80 Million | Skr59.70 Million | Skr13.90 Million | ▼ -1.7 pp |
| 2023 | 56.3% | Skr47.60 Million | Skr84.50 Million | Skr65.00 Million | Skr17.40 Million | ▼ -26.0 pp |
| 2022 | 82.3% | Skr146.30 Million | Skr177.70 Million | Skr161.00 Million | Skr14.70 Million | ▼ -8.7 pp |
| 2021 | 91.1% | Skr230.20 Million | Skr252.80 Million | Skr244.40 Million | Skr14.20 Million | ▲ +4.7 pp |
| 2020 | 86.4% | Skr146.40 Million | Skr169.50 Million | Skr160.30 Million | Skr13.90 Million | ▲ +44.1 pp |
| 2019 | 42.3% | Skr17.50 Million | Skr41.40 Million | Skr30.20 Million | Skr12.70 Million | ▼ -10.6 pp |
| 2018 | 52.9% | Skr23.70 Million | Skr44.80 Million | Skr33.60 Million | Skr9.90 Million | ▼ -28.1 pp |
| 2017 | 81.0% | Skr69.33 Million | Skr85.57 Million | Skr77.03 Million | Skr7.69 Million | ▲ +7.6 pp |
| 2016 | 73.4% | Skr35.75 Million | Skr48.70 Million | Skr47.35 Million | Skr11.60 Million | ▼ -16.1 pp |
| 2015 | 89.6% | Skr98.46 Million | Skr109.93 Million | Skr106.73 Million | Skr8.27 Million | ▲ +5.8 pp |
| 2014 | 83.7% | Skr32.53 Million | Skr38.85 Million | Skr36.92 Million | Skr4.39 Million | ▼ -9.0 pp |
| 2013 | 92.7% | Skr66.40 Million | Skr71.61 Million | Skr71.21 Million | Skr4.81 Million | ▲ +3.6 pp |
| 2012 | 89.1% | Skr21.75 Million | Skr24.39 Million | Skr25.27 Million | Skr3.52 Million | ▲ +9.9 pp |
| 2011 | 79.2% | Skr38.43 Million | Skr48.50 Million | Skr40.48 Million | Skr2.04 Million | ▲ +16.7 pp |
| 2010 | 62.6% | Skr6.09 Million | Skr9.74 Million | Skr7.63 Million | Skr1.54 Million | ▲ +57.3 pp |
| 2009 | 5.3% | Skr40.01K | Skr759.76K | Skr485.20K | Skr445.19K | — |